Pricing the third and largest biopharma IPO of 2026, Eikon Therapeutics Inc. raised $381 million in an upsized offering of 21.18 million shares of common stock at $18 each, the high point of its price range.
Newco ALTx Therapeutics Ltd. has launched with a £12.55 million (US$17.1 million) seed round to develop inhibitors of the alternative lengthening of telomeres (ALT) pathway, by which 10% to 15% of cancers become immortal.
Looking to fill a treatment gap, the U.S. Biomedical Advanced Research and Development Authority (BARDA) is launching the first stage of a $100 million prize competition to support development of broad-spectrum, small-molecule antiviral therapies targeting viruses in the Togaviridae and Flaviviridae families.
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Acadia, Astrazeneca, Daiichi Sankyo, Medtronic, Promega, Quanterix, Relay, Revealdx, Zeiss.
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Alto, Applied, Cycle, Eli Lilly, Hookipa, Illumina, Insilico, Menarini, Meiragtx, Neotrail, Newron, Owlet, Pacbio, Prophase, Setpoint, Stemline, WebAI, Zipbio, Zonsen.
Clinical updates for biopharma and med tech, including data readouts and publications: Alzheon, Avacta, Endospan, Inspira, NMD, Novo Nordisk, Olympus, Persica, Pfizer, Sagimet, Ultragenyx, Volta.
Biopharma and med-tech companies raising money in public or private financings, including: Adlai Nortye, Medx, Polaryx, Salspera, Sangamo, Sonovascular, Vaxcyte.
New hires and promotions in the biopharma and med-tech industries, including: Aptevo, B. Braun, Bicycle, Bioivt, CDR-Life, Hemostemix, Immorta, Kupando, Kyverna, Leonabio, Metabolon, Pyxis, Rigel, Spruce, Valo, Zelluna.
RSS
